Ascendis Pharma A/S

Ascendis Pharma A/S

95.22
BRL
+0.81
(+0.86%)
4.75EPS
15.63P/E
83.54BMarket Cap
Feb 17Next Earn

Ascendis Pharma A/S Documents

Q4 FY2025 · Presentation

Phase 2 COACH Trial Topline Week 52 Data · 18 pages

Read Ascendis Pharma A/S's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents